Therapy
Female CEOs
Health

Halozyme Therapeutics

$26.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.23%) As of 3:58 PM EDT today

Why Robinhood?

You can buy or sell HALO and other stocks, options, ETFs, and crypto commission-free!

About HALO

Halozyme Therapeutics, Inc. Common Stock, also called Halozyme Therapeutics, is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. Read More It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. The listed name for HALO is Halozyme Therapeutics, Inc. Common Stock.

CEO
Helen I. Torley
Employees
132
Headquarters
San Diego, California
Founded
1998
Market Cap
3.55B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.48M
High Today
$26.17
Low Today
$25.73
Open Price
$26.12
Volume
517.60K
52 Week High
$29.77
52 Week Low
$12.71

Collections

Therapy
Female CEOs
Health
Pharmaceutical
Biopharmaceutical
Biotechnology
Medical
Technology

HALO Earnings

-$0.24
-$0.08
$0.09
$0.25
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 9, After Hours

You May Also Like

AGNCO
IWP
EARS
ATEC
DYNF
SOAC
APPN
LIMAF
PCG-E
CMPI
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.
Buy HALO
Market Price
$26.00
Commissions
$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell HALO stock and options commission-free.
LearnBlogCareersHelpLog InSign Up